Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

ABUS Quote, Trading Chart, Arbutus Biopharma Corporation


home / stock / abus / abus quote

$3.30 Last:

5.1% Change Percent:

$3.2 Open:

$3.30 Previous Close:

$3.3 High:

$2.91 Low:

3,751,329 Volume:

03/05/2021 04:55:13 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-03-053.23.33.32.913,751,329
2021-03-043.573.143.63.014,423,673
2021-03-033.84523.643.883.62011,735,259
2021-03-023.883.833.913.79011,315,818
2021-03-013.93.843.983.742,066,048
2021-02-263.943.753.9453.662,408,799
2021-02-254.313.814.373.7753,309,419
2021-02-243.934.424.493.93,699,674
2021-02-234.163.834.183.643,870,899
2021-02-224.44.294.5554.252,373,845
2021-02-194.344.394.654.32,318,344
2021-02-184.374.284.434.221,832,488
2021-02-174.54.414.58114.282,033,058
2021-02-164.474.494.64014.362,317,686
2021-02-154.384.334.41484.2351,777,428
2021-02-124.384.334.41484.2351,771,333
2021-02-114.414.384.614.152,648,179
2021-02-104.554.434.734.273,340,894
2021-02-0954.475.144.456,914,118
2021-02-084.294.844.894.2311,413,083
Stock Information

Arbutus Biopharma Corporation Company Name:

ABUS Stock Symbol:

NASDAQ Market:

Arbutus Biopharma Corporation Website:

ABUS Quote, Trading Chart, Arbutus Biopharma Corporation

MENU
ABUS ABUS Quote ABUS Short ABUS News ABUS Articles ABUS Message Board
Get ABUS Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT ABUS NEWS
  • ABUS - Arbutus Biopharma (ABUS) Q4 2020 Earnings Call Transcript

    Image source: The Motley Fool. Arbutus Biopharma (NASDAQ: ABUS) Q4 2020 Earnings Call Mar 04, 2021 , 8:45 a.m. ET Operator Continue reading For further details see: Arbutus Biopharma (ABUS) Q4 2020 Earnings Call Transcript

  • ABUS - Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update

    AB-729, Arbutus’ proprietary subcutaneously delivered RNAi agent, demonstrates robust and continuous declines in hepatitis B surface antigen (HBsAg) in subjects with chronic hepatitis B (HBV) with favorable safety and tolerability data Reductions in HBsAg seen i...

  • ABUS - Arbutus to Participate at H.C. Wainwright Global Life Sciences Conference

    WARMINSTER, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus (HBV) infection, as well as therapies to treat coronaviruses (includi...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.



Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News